X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5161) 5161
Book Review (1541) 1541
Publication (263) 263
Book Chapter (44) 44
Newsletter (16) 16
Conference Proceeding (15) 15
Magazine Article (12) 12
Trade Publication Article (11) 11
Dissertation (4) 4
Newspaper Article (2) 2
Transcript (2) 2
Web Resource (2) 2
Data Set (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3809) 3809
humans (3189) 3189
diabetes mellitus, type 2 - drug therapy (2262) 2262
type 2 diabetes (2000) 2000
diabetes (1796) 1796
male (1672) 1672
endocrinology & metabolism (1605) 1605
hypoglycemic agents - therapeutic use (1499) 1499
sitagliptin (1347) 1347
female (1276) 1276
dipeptidyl-peptidase iv inhibitors - therapeutic use (1223) 1223
animals (1135) 1135
glucose (1092) 1092
pharmacology & pharmacy (1076) 1076
middle aged (1067) 1067
glucagon-like peptide-1 (996) 996
double-blind (964) 964
metformin (888) 888
dipeptidyl peptidase-4 inhibitor (881) 881
aged (864) 864
diabetes mellitus (846) 846
glycemic control (825) 825
insulin (791) 791
treatment outcome (775) 775
hypoglycemic agents (718) 718
hypoglycemic agents - adverse effects (702) 702
diabetes mellitus, type 2 - blood (701) 701
safety (675) 675
dipeptidyl-peptidase iv inhibitors - pharmacology (668) 668
drug therapy (654) 654
care and treatment (640) 640
analysis (633) 633
sitagliptin phosphate (631) 631
type 2 diabetes mellitus (613) 613
adult (612) 612
efficacy (596) 596
dipeptidyl peptidase-4 inhibitors (572) 572
blood glucose - metabolism (563) 563
type-2 diabetes-mellitus (560) 560
blood glucose - drug effects (549) 549
risk factors (546) 546
diabetes therapy (536) 536
internal medicine (533) 533
dextrose (528) 528
drug therapy, combination (525) 525
hypoglycemic agents - administration & dosage (522) 522
hypoglycemic agents - pharmacology (513) 513
dipeptidyl-peptidase iv inhibitors - adverse effects (507) 507
research (477) 477
clinical trials (472) 472
vildagliptin (465) 465
mellitus (464) 464
medicine & public health (462) 462
dpp-4 inhibitor (450) 450
mice (435) 435
medicine, general & internal (432) 432
diabetes mellitus, type 2 - complications (431) 431
rats (420) 420
glucagon (413) 413
dipeptidyl peptidase 4 - metabolism (412) 412
hyperglycemia (404) 404
adamantane - analogs & derivatives (398) 398
dpp-4 inhibitors (396) 396
hypoglycemia (394) 394
inhibitors (393) 393
glycated hemoglobin a - metabolism (391) 391
beta-cell function (384) 384
dipeptidyl-peptidase iv inhibitors - administration & dosage (369) 369
insulin resistance (367) 367
triazoles - therapeutic use (364) 364
pyrazines - therapeutic use (363) 363
double-blind method (359) 359
metformin - therapeutic use (352) 352
peptides (345) 345
peptidase (343) 343
cardiac & cardiovascular systems (342) 342
diabetes mellitus, type 2 - metabolism (340) 340
health aspects (340) 340
therapy (330) 330
glp-1 (316) 316
abridged index medicus (314) 314
dosage and administration (314) 314
studies (309) 309
review (307) 307
pharmacokinetics (306) 306
improves glycemic control (303) 303
patients (302) 302
risk (301) 301
inhibitor (299) 299
linagliptin (296) 296
cardiovascular disease (289) 289
glycosylated hemoglobin (288) 288
mortality (288) 288
monotherapy (282) 282
sodium-glucose transporter 2 - antagonists & inhibitors (281) 281
medicine, research & experimental (277) 277
dose-response relationship, drug (268) 268
diabetes mellitus, type 2 - physiopathology (261) 261
medical research (258) 258
endocrinology (257) 257
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5118) 5118
French (31) 31
German (25) 25
Korean (18) 18
Japanese (13) 13
Spanish (10) 10
Hungarian (6) 6
Russian (6) 6
Chinese (5) 5
Czech (5) 5
Dutch (2) 2
Portuguese (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Drug Discovery, ISSN 1474-1776, 02/2007, Volume 6, Issue 2, pp. 109 - 110
Journal Article
Diabetes Care, ISSN 0149-5992, 03/2016, Volume 39, Issue 3, pp. 455 - 464
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2013, Volume 36, Issue 12, pp. 4015 - 4021
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2012, Volume 97, Issue 9, pp. 3333 - 3341
Context: Sitagliptin is an inhibitor of the enzyme dipeptidyl peptidase-IV (DPP-IV), which degrades the incretins, glucagon-like peptide-1 and... 
IMMUNITY | DIPEPTIDYL-PEPTIDASE-IV | HEALTHY-SUBJECTS | INSULIN-RESISTANCE | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | RECEPTOR | MICE | CD26 | INHIBITOR SITAGLIPTIN | Glycated Hemoglobin A - analysis | Tumor Necrosis Factor-alpha - metabolism | Interleukin-6 - analysis | Dipeptidyl Peptidase 4 - metabolism | Prospective Studies | Humans | Middle Aged | Male | Monocytes - metabolism | I-kappa B Kinase - analysis | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | C-Reactive Protein - metabolism | MAP Kinase Kinase 4 - analysis | MAP Kinase Kinase 4 - metabolism | I-kappa B Kinase - metabolism | Glucagon-Like Peptide 1 - analysis | Adult | Female | Sitagliptin Phosphate | C-Reactive Protein - analysis | Interleukin-6 - metabolism | Toll-Like Receptor 4 - analysis | Dipeptidyl Peptidase 4 - analysis | Anti-Inflammatory Agents, Non-Steroidal | Blood Glucose - analysis | Double-Blind Method | Glucagon-Like Peptide 1 - metabolism | Cell Separation | Toll-Like Receptor 2 - metabolism | Receptors, CCR2 - analysis | Toll-Like Receptor 4 - metabolism | Blotting, Western | Tumor Necrosis Factor-alpha - analysis | Monocytes - drug effects | Triazoles - pharmacology | Receptors, CCR2 - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Toll-Like Receptor 2 - analysis | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Index Medicus | Abridged Index Medicus | Endocrine Research
Journal Article
10/2011
Sitagliptin is a newer oral hypoglycemic drug of the dipeptidyl peptidase-IV inhibitor class. It appears to be a promising newer oral hypoglycemic agent. The... 
sitagliptin | Dipeptidyl peptidase inhibitor | hemolysis
Web Resource
Diabetologia, ISSN 0012-186X, 8/2012, Volume 55, Issue 8, pp. 2267 - 2275
Journal Article
Diabetic Medicine, ISSN 0742-3071, 11/2012, Volume 29, Issue 11, pp. e417 - e424
Aims  To test the hypothesis that glycaemic control achieved when switching sitagliptin to exenatide twice daily plus metformin is non‐inferior to adding... 
MANAGEMENT | PHARMACOKINETICS | SAFETY | GLUCOSE | ENDOCRINOLOGY & METABOLISM | INCRETIN-BASED THERAPIES | PHARMACODYNAMICS | MELLITUS | Triazoles - administration & dosage | Hypoglycemia - epidemiology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Pyrazines - administration & dosage | Argentina - epidemiology | Male | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Peptides - administration & dosage | Diabetes Mellitus, Type 2 - epidemiology | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Adult | Female | Hypoglycemia - blood | Metformin - administration & dosage | Sitagliptin Phosphate | Republic of Korea - epidemiology | Double-Blind Method | Drug Administration Schedule | Mexico - epidemiology | Metformin - pharmacology | India - epidemiology | Treatment Outcome | Greece - epidemiology | Australia - epidemiology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Germany - epidemiology | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Triazoles - pharmacology | Diabetes Mellitus, Type 2 - blood | Adolescent | Aged | Venoms - pharmacology | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Type 2 diabetes | Clinical trials | Care and treatment | Hypoglycemic agents | Blood sugar | Diabetes therapy | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9739, pp. 431 - 439
Journal Article
DIABETES CARE, ISSN 0149-5992, 11/2013, Volume 36, Issue 11, pp. 3430 - 3435
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2018, Volume 20, Issue 6, pp. 1427 - 1434
Aim: Pooled efficacy studies suggest that glycaemic responses to dipeptidyl-peptidase 4 inhibitors in type 2 diabetes are greatest in Asians, who may also... 
glycaemic control | sitagliptin | type 2 diabetes | ethnicity | EFFICACY | DPP-4 INHIBITOR | LINAGLIPTIN | BETA-CELL FUNCTION | ADD-ON THERAPY | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | ENDOCRINOLOGY & METABOLISM | SECRETION | TYPE-2 DIABETES-MELLITUS | GLUCOSE-TOLERANCE | PHARMACODYNAMIC EVALUATION | African Continental Ancestry Group - ethnology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Asia - ethnology | Hispanic Americans - statistics & numerical data | Male | European Continental Ancestry Group - ethnology | Diabetes Mellitus, Type 2 - ethnology | Hypoglycemic Agents - administration & dosage | Female | Drug Therapy, Combination | Sitagliptin Phosphate - administration & dosage | Acarbose - administration & dosage | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Diabetic Angiopathies - blood | Diabetic Angiopathies - drug therapy | Diabetic Angiopathies - ethnology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Glycoside Hydrolase Inhibitors - administration & dosage | Diabetes Mellitus, Type 2 - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Glycosylated hemoglobin | Evaluation | Acarbose | Analysis | Peptidase | Diabetes mellitus | Diabetes | Metformin | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Insulin | Asians | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article